IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -83.95% | -87.73% | -82.48% | -79.69% | -72.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -83.95% | -87.73% | -82.48% | -79.69% | -72.43% |
| Cost of Revenue | -17.16% | -41.48% | -52.55% | -56.90% | -53.96% |
| Gross Profit | -261.54% | -756.69% | -2,561.54% | -461.80% | -125.66% |
| SG&A Expenses | -66.17% | -59.63% | -49.89% | -38.50% | -39.51% |
| Depreciation & Amortization | 12.58% | -44.69% | 35.54% | 53.94% | 11.54% |
| Other Operating Expenses | -8.30% | -16.45% | -20.56% | -16.64% | -21.63% |
| Total Operating Expenses | -36.86% | -37.42% | -31.54% | -26.59% | -31.96% |
| Operating Income | 33.98% | 32.83% | 24.98% | 18.41% | 25.25% |
| Income Before Tax | 29.05% | 63.63% | 46.47% | 45.32% | 44.28% |
| Income Tax Expenses | -1,058.82% | -1,458.33% | -490.00% | -700.00% | 125.76% |
| Earnings from Continuing Operations | 30.17% | 64.33% | 46.91% | 45.74% | 44.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.17% | 64.33% | 46.91% | 45.74% | 44.09% |
| EBIT | 33.98% | 32.83% | 24.98% | 18.41% | 25.25% |
| EBITDA | 30.87% | 29.95% | 27.85% | 21.48% | 28.91% |
| EPS Basic | 76.67% | 90.28% | 66.85% | 56.68% | 48.06% |
| Normalized Basic EPS | 84.81% | 95.53% | 71.81% | 56.49% | 48.23% |
| EPS Diluted | 76.94% | 90.69% | 68.62% | 57.98% | 49.69% |
| Normalized Diluted EPS | 84.80% | 95.51% | 71.71% | 56.32% | 48.13% |
| Average Basic Shares Outstanding | 635.67% | 317.42% | 81.28% | 36.13% | 9.69% |
| Average Diluted Shares Outstanding | 634.24% | 316.33% | 80.77% | 35.68% | 9.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |